P-POSSUM Falls Short: Predicting Morbidity in Ovarian Cancer (OC) Cytoreductive Surgery
The P-POSSUM scale shows poor performance for predicting morbidity in OC CRS. New validated and accurate model(s) are necessary for predicting surgical morbidity. Our proposed model incorporates additional variables to improve P-POSSUM's performance. This requires further development and validation.
Authors
- Caitlin T. Fierheller (ORCID: https://orcid.org/0000-0001-9583-3061)
- Saurabh Phadnis (ORCID: https://orcid.org/0000-0002-0959-3514)
- Ranjit Manchanda (ORCID: https://orcid.org/0000-0003-3381-5057)
- Alexandra Lawrence (ORCID: https://orcid.org/0000-0002-8911-4252)
- Jacqueline Sia (ORCID: https://orcid.org/0000-0002-1820-3194)
- Oleg B. Blyuss (ORCID: https://orcid.org/0000-0002-0194-6389)
- Mark Brincat (ORCID: https://orcid.org/0000-0001-7995-8331)
- James Dilley (ORCID: https://orcid.org/0000-0002-1108-0048)
- Mevan Gooneratne
- Fatima El-Khouly
- Rowan Miller (ORCID: https://orcid.org/0000-0002-2400-1716)
- Ashwin Kalra (ORCID: https://orcid.org/0000-0002-5541-226X)
- Samuel Oxley (ORCID: https://orcid.org/0000-0003-1967-813X)
- Arjun Jeyarajah
- Parvesh Verma
- Michail Sideris (ORCID: https://orcid.org/0000-0002-4199-6700)
- Elly Brockbank
- Tom Abbott (ORCID: https://orcid.org/0000-0002-8664-3001)
- Wei Xia (ORCID: https://orcid.org/0000-0001-5005-059X)
- Ching Ling Pang
- Seema Shah
- Subhasheenee Ganesan
Institutions
- University College Hospital (GB)
- Barking, Havering And Redbridge University Hospitals NHS Trust (GB)
- Queen Mary University of London (GB)
- Barts Health NHS Trust (GB)
- Royal London Hospital (GB)
- London School of Hygiene & Tropical Medicine (GB)
- MRC Clinical Trials Unit at UCL (GB)
- Scientific Center of Children's Health (RU)
- University College London (GB)
Publication Details
- Journal
- Cancers
- Published
- 2025-10-24
- DOI
- https://doi.org/10.3390/cancers17213421
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca
- Barts Charity
- Israel National Institute for Health Policy Research
- Barts Health NHS Trust
- British Gynaecological Cancer Society